VEGFR-3 Expression Is Restricted to Blood and Lymphatic Vessels in Solid Tumors

Cancer Cell

Volumn 13, Issue 6, 2008, Pages 554-556

  Petrova, Tatiana V ^a   Bono, Petri ^b   Holnthoner, Wolfgang ^a   Chesnes, Jessica ^c   Pytowski, Bronislaw ^c   Sihto, Harri ^b   Laakkonen, Pirjo ^a   Heikkilä, Päivi ^b   Joensuu, Heikki ^a,b   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN RECEPTOR 3;

BLOOD VESSEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH VESSEL; LYMPHANGIOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOLID TUMOR; TUMOR VASCULARIZATION;

EID: 44449155430     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2008.04.022     Document Type: Letter

References (20)

1. Achen M.G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A.F., Alitalo K., and Stacker S.A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95 (1998) 548-553
2. Alitalo K., and Carmeliet P. Molecular mechanism of lymphangiogenesis in health and disease. Cancer Cell 1 (2002) 219-227
3. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
4. Arinaga M., Noguchi T., Takeno S., Chujo M., Miura T., and Uchida Y. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung cancer. Cancer 97 (2003) 457-464
5. Beierle E.A., Dai W., Langham Jr. M.R., Copeland III E.M., and Chen M.K. Expression of VEGF receptors in cocultured neuroblastoma cells. J. Surg. Res. 119 (2004) 56-65
6. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., and Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15 (1996) 290-298
7. Kaushal V., Mukunyadzi P., Dennis R.A., Siegel E., Johnson D.E., and Kohli M. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: Expression of lymphangiogenic markers is associated with advanced-stage disease. Clin. Cancer Res. 11 (2005) 584-593
8. Laakkonen P., Waltari M., Holopainen T., Pytowski B., Steiner P., Hicklin D., Persaud K., Tonra J.R., Witte L., and Alitalo K. Vascular endothelial growth factor receptor-3 (VEGFR-3) is involved in tumor angiogenesis and growth. Cancer Res. 67 (2007) 593-599
9. Leclers D., Durand K., Cook-Moreau J., Rabinovitch-Chable H., Sturtz F.G., and Rigaud M. VEGFR-3, VEGF-C and VEGF-D mRNA quantification by RT-PCR in different human cell types. Anticancer Res. 26 (2006) 1885-1891
10. Li Q., Dong X., Gu W., Qiu X., and Wang E. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer. Chin. Med. J. (Engl.) 116 (2003) 727-730
11. Pajusola K., Aprelikova O., Korhonen J., Kaipainen A., Pertovaara L., Alitalo R., and Alitalo K. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52 (1992) 5738-5743
12. Pajusola K., Aprelikova O., Pelicci G., Weich H., Claesson-Welsh L., and Alitalo K. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 9 (1994) 3545-3555
13. Paavonen K., Puolakkainen P., Jussila L., Jahkola T., and Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 156 (2000) 1499-1504
14. Partanen T.A., Alitalo K., and Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86 (1999) 2406-2412
15. Shields J.D., Borsetti M., Rigby H., Harper S.J., Mortimer P.S., Levick J.R., Orlando A., and Bates D.O. Lymphatic density and metastatic spread in human malignant melanoma. Br. J. Cancer 90 (2004) 693-700
16. Stacker S.A., Achen M.G., Jussila L., Baldwin M.E., and Alitalo K. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2 (2002) 573-583
17. Su J.-L., Yang P.-C., Shih J.-Y., Yang C.-Y., Wei L.-H., Hsieh C.-Y., Chou C.-H., Jeng Y.-M., Wang M.-Y., Chang K.-J., et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9 (2006) 209-223
18. Valtola R., Salven P., Heikkila P., Taipale J., Joensuu H., Rehn M., Pihlajaniemi T., Weich H., deWaal R., and Alitalo K. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154 (1999) 1381-1390
19. Veikkola T., Lohela M., Ikenberg K., Makinen T., Korff T., Saaristo A., Petrova T., Jeltsch M., Augustin H.G., and Alitalo K. Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function. FASEB J. 17 (2003) 2006-2013
20. Witte C., Thomas A., Ali N., Carlson N., and Younes M. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res. 22 (2002) 1463-1466